Trade Articles
Pharma Manufacturing | March 2023
Streamlining HPAPI development: How to manage highly potent APIs through a preclinical testing process
Drug Discovery and Development | February 2023
Overcoming the challenges of metabolite identification and profiling for developing oligonucleotides
Drug Discovery and Development | November 2022
How MetID studies can improve safety and efficacy in PROTAC drugs
GEN News | November 2022
Bioanalysis Considerations for CAR T-Cell Therapies
Contract Pharma | October 2022
Comprehensive Bioanalysis of ADCs in DMPK Studies
American Pharmaceutical Review | August 2022
Antibody-Drug Conjugates (ADCs): Potent Cancer Killers with PK Challenges
Bioanalysis Zone | June 2022
Utilizing Monoclonal Antibodies to Regulate Checkpoint Proteins & Boost Immune Response
Drug Discovery & Development | February 2022
5 questions drug developers need to ask when vetting laboratory testing partners
American Pharmaceutical Review | December 2021
Improving Preclinical Outcomes: De-Risking Your Drug Development Program
Contract Pharma | June 2021
Preparing for Preclinical Testing: A Readiness Checklist
Drug Discovery & Development | May 2021
Managing critical reagents through drug development
AAPS Journal | May 2021
Bioanalysis in the Age of New Drug Modalities
Drug Discovery & Development | April 2021
Analyzing FDA guidance on DDI studies for therapeutic proteins
Drug Metabolism and Disposition | January 2023
Detection and characterization of in vitro payload-containing catabolites of non-cleavable ADCs by high-resolution mass spectrometry and multiple data-mining tools
Bioanalysis Zone | November 2022
Bioanalytical considerations for gene and cell therapeutic products
Drug Discovery and Development | October 2022
Preparing an IND submission: Here is what drug sponsors should anticipate
Bioanalysis Zone | August 2022
Examining the dominant bioanalytical methods for Oligo development
OnDrug Delivery | August 2022
Dissecting the Delicate Delivery Process for Ocular Gene Therapy
Drug Discovery & Development | July 2022
Bioanalytical method development and validation using Quanterix’s Simoa platform
Pharmaceutical Outsourcing | May 2022
Protein Biomarkers: The Correlation Between Proteins, Health Conditions and Exogenous Products
OnDrug Delivery | March 2022
Drug Discovery & Development | December 2021
The opportunities and challenges inherent in using protein biomarkers for new drug development
Genetic Engineering and Biotechnology News | November 2021
Using In Vitro–In Vivo Extrapolation to Predict Human Clearance
Regulatory Focus | June 2021
The transition to ICH M10 and its impact on global submissions
Life Science Leader | May 2021
Improving Submission Quality: Preparing For Regulatory Differences
PharmaManufacturing | March 2021
Winning the drug development relay